TVRD — Tvardi Therapeutics Share News
0.000.00%
Last trade - 00:00Tvardi Therapeutics Q2 net loss slightly lower estimates
Brief: Tvardi Therapeutics Inc Q2 Net Income USD -6.5 Million Vs. IBES Estimate USD -6.54 Million
Tvardi Therapeutics, Inc. expected to post a loss of 70 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:50 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:50 PM
NASDAQ RESUMED AT 03:49 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:40 PM
U.S. STOCKS ON THE MOVE-Vera Therapeutics, Vera Therapeutics, Nvidia
U.S. STOCKS ON THE MOVE-Revolution Medicines, Vivani Medical, Nvidia
U.S. STOCKS ON THE MOVE-Nvidia, Crinetics Pharmaceuticals, Rivian Automotive
Tvardi rises as oral inflammation drug shows early-stage trial promise
Tvardi Therapeutics Q1 net loss narrows
Tvardi Therapeutics reports larger-than-expected Q4 net loss
Brief: Tvardi Therapeutics Tti-101 Shows 9.4% Fibrosis Score Decrease Versus 2.4% Placebo
U.S. STOCKS ON THE MOVE-Keurig Dr Pepper, Ardelyx, Vertiv
U.S. STOCKS ON THE MOVE-Broadcom, JPMorgan, Enpro
Tvardi Therapeutics plunges after lung disease drug fails to meet trial goals
U.S. STOCKS ON THE MOVE-Bloom Energy, Argan, Endra Life Sciences
Tvardi Therapeutics drops after lung disease drug fails to meet trial goals